Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02897570
Other study ID # Colazioni/4
Secondary ID
Status Completed
Phase N/A
First received August 26, 2016
Last updated September 13, 2016
Start date October 2013
Est. completion date December 2014

Study information

Verified date September 2016
Source Ospedale San Donato
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

This study aims at assessing the effects of glucose and different types of breakfast on metabolic and neurofunctional responses in healthy individuals.

Twelve healthy subjects, on a stable diet, in a randomized-crossover fashion, received either a 50 g glucose load (control) or one of these breakfast:

B1: milk (125ml) and cereals (30g); B2: milk (220ml), apple (200g) and cream chocolate filled sponge cake (30g); B3: milk (125ml), bread (50g), apple (150g) and hazelnut cream chocolate (15g). Prior and upon completion of each tolerance test, an EEG was performed to measure frontal P300-evoked potentials.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- BMI 18.5 - 24.9 kg/m2

- normal glucose tolerance

- stable diet

Exclusion Criteria:

- type 1 and type 2 diabetes

- impaired glucose tolerance

- dyslipidemia

- metabolic syndrome

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Glucose
50g of glucose dissolved in 250 to 300ml of water was drunk. Prior and upon completion of each glucose tolerance test, an EEG was performed.
Milk & Cereals
A breakfast (B1) including a glass of milk (125ml) and 30 g-corn flakes was consumed. Prior and upon completion of each tolerance test, an EEG was performed
Milk, apple & snack
A breakfast (B2) including a glass of milk (220ml), an apple (200g), a cream chocolate filled sponge cake (30g) was consumed. Prior and upon completion of each meal tolerance test, an EEG was performed.
Milk, apple & bread w/ cream
A breakfast (B3) including a glass of milk (125ml), an apple (150g), bread (50g, hazelnut chocolate cream (15g) was consumed. Prior and upon completion of each meal tolerance test, an EEG was performed.
Device:
EEG_pre
Electroencephalography (EEG) was performed prior each tolerance test to assess frontal P300-evoked potentials
EEG_post
Electroencephalography (EEG) was performed upon completion of each tolerance test to assess frontal P300-evoked potentials

Locations

Country Name City State
Italy San Donato Hospital San Donato Milanese MI

Sponsors (2)

Lead Sponsor Collaborator
Ospedale San Donato Soremartec Italia S.r.l.

Country where clinical trial is conducted

Italy, 

References & Publications (5)

Barclay AW, Brand-Miller JC, Wolever TM. Glycemic index, glycemic load, and glycemic response are not the same. Diabetes Care. 2005 Jul;28(7):1839-40. — View Citation

Benedini S, Codella R, Caumo A, Marangoni F, Luzi L. Different circulating ghrelin responses to isoglucidic snack food in healthy individuals. Horm Metab Res. 2011 Feb;43(2):135-40. doi: 10.1055/s-0030-1269900. Epub 2011 Jan 10. — View Citation

Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001 Aug;50(8):1714-9. — View Citation

Esposito K, Giugliano D. Low-glycemic load diet and resting energy expenditure. JAMA. 2005 Mar 9;293(10):1189; auhor reply 1189-90. — View Citation

Franz MJ. The glycemic index: not the most effective nutrition therapy intervention. Diabetes Care. 2003 Aug;26(8):2466-8. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Effect of glucose vs different kind of breakfasts on cognitive performances via brain evoked-potentials measure On the same morning of the glucose tolerance test, before and 180 min after consumption, an EEG was performed to record P300 wave-evoked potentials. The incremental (post-pre) frontal P300 potential was assessed as a "change" ( before and 180 min after consumption) Yes
Secondary Effect of glucose vs different kind of breakfasts on AUC_glycemia in healthy subjects The incremental area under plasma glucose concentration curve (AUC_glycemia) was used as summary measures of the metabolic responses resulting from the intake of either glucose or one of the 3 breakfasts. The incremental AUC was calculated as the difference between the total AUC and the product of the basal, pre-test concentration time during the experiment (i.e., 120 min). Blood samples are drawn at -15, 0, 15, 30, 45, 60, 75, 90, 120 minutes with respect to the ingestion. Yes
Secondary Effect of glucose vs different kind of breakfasts on AUC_ghrelinemia in healthy subjects. The incremental area under plasma ghrelin concentration curve (AUC_ghrelinemia) was used as summary measures of the metabolic responses resulting from the intake of either glucose or one of the 3 breakfasts. The incremental AUC was calculated as the difference between the total AUC and the product of the basal, pre-test concentration time during the experiment (i.e., 120 min). Blood samples are drawn at -15, 0, 15, 30, 45, 60, 75, 90, 120 minutes with respect to the ingestion. Yes
Secondary Effect of glucose vs different kind of breakfasts on AUC_insulinemia in healthy subjects. The incremental area under plasma insulim concentration curve (AUC_insulinemia) was used as summary measures of the metabolic responses resulting from the intake of either glucose or one of the 3 breakfasts. The incremental AUC was calculated as the difference between the total AUC and the product of the basal, pre-test concentration time during the experiment (i.e., 120 min). Blood samples are drawn at -15, 0, 15, 30, 45, 60, 75, 90, 120 minutes with respect to the ingestion. Yes
See also
  Status Clinical Trial Phase
Completed NCT00600470 - Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior Disorders Phase 1/Phase 2
Completed NCT03698240 - Mindfulness-based Program for Children With Disruptive Behavior Disorder N/A
Completed NCT02766101 - Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges N/A
Recruiting NCT04946253 - SKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care N/A
Completed NCT00402857 - Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders Phase 3
Completed NCT03597789 - Tantrum Tamers 2.0: The Role of Emotion N/A
Recruiting NCT01350986 - Guided Self-Help for Parents of Children With Externalizing Problem Behavior N/A
Completed NCT00163865 - A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents N/A
Completed NCT02893852 - Effects of CO-OP Approach on Activity and Participation of Brazilian Children With Developmental Coordination Disorder N/A
Completed NCT01940978 - A Study of Combination Therapy in Children With ADHD Phase 4
Terminated NCT02094612 - Effectiveness of the Quotient® ADHD Assessment in a System of Care N/A
Completed NCT02305134 - Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial Phase 1/Phase 2
Completed NCT03927612 - Virtual Reality to Improve Social Perspective Taking N/A
Completed NCT03976570 - The Effect of Occupational Therapy on Subthreshold Attention Deficit Hyperactivity Disorder N/A
Recruiting NCT04238403 - Peer Professionals to Increase Capacity to Treat ADHD N/A
Completed NCT00218114 - Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults Phase 3
Completed NCT01919073 - Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers N/A
Completed NCT00236444 - A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders Phase 3
Completed NCT00001233 - Study of Children at Risk for Disruptive Behavior Disorders N/A
Recruiting NCT05683756 - A Sleep Focused Parenting Intervention for Preschool Aged Children at Risk for ADHD N/A